جست‌وجوی استاد و پژوهشگر

Kelly Ceyzériatمشاهده پروفایل

پژوهشگر

• Neuroscience
• Neuroimaging
• Molecular Imaging
• +۶ مورد دیگر

Kelly Ceyzériat is a Research Staff Scientist at the Center for Biomedical Imaging (CIBM), University of Geneva, within the PET HUG-UNIGE Molecular Imaging Section. She joined CIBM in January 2022 to develop independent research on Alzheimer's disease mechanisms, with a focus on hormonal and neuroinflammatory modulators. Previously, she collaborated with Prof. Valentina Garibotto (2018) on radiation therapy for Alzheimer's and with Prof. Philippe Millet (2021) on glial cells and neuroinflammation. Her educational background: PhD in Neuroscience, Paris-Saclay University, France (2014-2017) Her research expertise lies at the intersection of neuroimaging and neurodegenerative disorders . She specializes in Alzheimer's disease research, investigating the roles of astrocytes and neuroinflammation using PET and SPECT molecular imaging. Her methodological toolkit includes in vivo imaging, animal behavior assessments, stereotaxic surgery, histology, biochemistry, flow cytometry, and transcriptomics. Current projects aim to unravel the mechanisms of Alzheimer's pathology progression. Dr. Ceyzériat is an active member of the Molecular Imaging Section at CIBM, which provides advanced imaging infrastructure and fosters collaboration with 7T MRI experts for cutting-edge neuroscience research.

• Magnetic Particle Imaging
• Nanoparticle Synthesis
• Biomedical Engineering
• +۳ مورد دیگر

Kerstin Lüdtke-Buzug is a Senior Research Scientist at the Institute of Medical Engineering, University of Lübeck, where she has been a member of the scientific team since 2007. She also serves as Radiation Protection Officer at IMT, Vice Equal Opportunity Manager at the University of Lübeck, and is a Member of the Equal Opportunity Council. Her academic background includes a Diplom-Chemikerin degree from Christian-Albrechts-University of Kiel (1990) and a Ph.D. from the Medical University of Lübeck (1994). Dr. Lüdtke-Buzug's research focuses on Magnetic Particle Imaging (MPI), nanoparticle synthesis, and tracer development for medical applications. Her work spans biochemical engineering, magnetic resonance imaging, nuclear imaging, and X-ray based imaging. She has made significant contributions to the development of superparamagnetic iron oxide nanoparticles (SPIONs) for sentinel lymph node biopsy in breast cancer and other medical applications. Her publication record shows consistent research output with 15+ publications annually in high-impact journals. The research trends demonstrate a strong focus on MPI technology development, medical instrumentation, and clinical applications particularly in interventional radiology, cardiovascular medicine, and oncology. Her work often involves collaboration with clinical departments for translational research. As Radiation Protection Officer, she oversees safety protocols related to radiation and magnetic fields in research settings. Her role as Vice Equal Opportunity Manager reflects her commitment to diversity and inclusion in academic environments. Dr. Lüdtke-Buzug has supervised student projects and contributed to teaching in the Medical Engineering Science program. She also consults for Nandatec, a nano-biotechnology start-up, since 2013, bridging academic research with commercial applications.

Matthew Naanlep Tankoمشاهده پروفایل

دانشیار

• Oncology
• Infectious Diseases
• Pathology Education
• +۷ مورد دیگر

Matthew Naanlep Tanko, MD , is an Associate Professor of Practice in the Department of Medicine at the School of Medicine, Nazarbayev University , Kazakhstan. He has held senior academic and administrative roles across Africa and Central Asia, including Founding Head of Pathology and Dean of Clinical Sciences at Kampala International University , and Founding Head of Pathology and Interim Dean at the University of Botswana . Education: MBBS – University of Jos, Nigeria (1996) FMCPath – National Postgraduate Medical College of Nigeria (2004) Geraldine C Colby Scholarship – Mayo Clinic, Scottsdale, AZ, USA (2012) Health Systems Management – Galilee International Management Institute, Israel (2013) Research Interests: Dr. Tanko’s work focuses on oncology , particularly gastric, liver, and gynecologic cancers , as well as infectious disease pathology , including HIV-related liver disease and Helicobacter pylori . He is deeply invested in pathology education reform and health systems strengthening , especially in low-resource settings. His recent projects include genomic profiling of pediatric diseases , minimally invasive autopsy techniques , and international pathology residency accreditation . Scientific Awards: Geraldine C Colby Scholarship – Mayo Visiting Clinician Programme (2012) Distinguished Article of the Year – Colección Trabajos Distinguidos, Serie Oncología (2012) Leadership & Grants: Dr. Tanko has led multiple international health and education initiatives. He served as Principal Investigator on projects such as Clinicopathologic Features of DNA Mismatch Repair Deficient Colorectal Cancer (2019–2020), Pediatric Celiac Disease in Kazakhstan (2020–2022), and Proteolytic processing of TAM receptors in bladder cancer (2023–2025). Labs & Teams: Dr. Tanko has established and led pathology departments and training programs in Uganda, Botswana, and Kazakhstan , fostering international collaborations with institutions such as Mayo Clinic , College of American Pathologists , and British Division of IAP .

• Hematopathology
• Genetics
• Mechanisms of Cancer
• +۴ مورد دیگر

Michael A Linden is a Professor at the Laboratory Medicine and Pathology department of the University of Minnesota . He specializes in Hematopathology , Genetics , and Mechanisms of Cancer , with a focus on Plasma Cell Neoplasms , Multiple Myeloma , and Immunophenotyping . Research Interests: His work spans diagnostic challenges in plasma cell neoplasms, immune modulation post-transplantation, canine lymphoma prevention, and stress-immune interactions. Projects: Current projects include CD83-targeted therapies , Canine Lymphoma Early Detection , and clinical trials for Iberdomide in Multiple Myeloma . Article Trends: Recent publications emphasize Ki-67 in Follicular Lymphoma , Flow Cytometry applications , and cross-species oncology comparisons . Collaborations: Active in the Alliance for Clinical Trials in Oncology and partnerships with Morris Animal Foundation , NIH , and Health Research, Inc.

• Immunology
• Dendritic Cell Research
• Cancer Immunotherapy
• +۴ مورد دیگر

Associate Professor Georgina Clark is a distinguished immunologist at The University of Sydney's School of Medicine, serving as Group Leader of Dendritic Cell Research at the ANZAC Research Institute and holding a Senior Research Fellow position. Her research focuses on developing therapeutic monoclonal antibodies targeting human myeloid and dendritic cell surface molecules for cancer immunotherapy applications. Dr. Clark's primary research interests include: Developing immune therapies for hematological malignancies Understanding dendritic cell biology in cancer immunity Characterizing cell surface molecules on immune cells Developing monoclonal antibodies for therapeutic applications Investigating leucocyte membrane molecules, particularly CD300 family members Her work demonstrates a consistent focus on translating basic immunology discoveries into clinical applications, with particular emphasis on dendritic cell-based cancer immunotherapies. Analysis of her recent publications reveals strong themes in acute myeloid leukemia research, dendritic cell targeting strategies, and the development of novel monoclonal antibodies against cell surface markers like CD300f, CD83, and CD302. Dr. Clark has received significant research funding including a 2017 Cancer Institute NSW Translational Program Grant for 'Therapeutic Antibody Translation into Patients' and a 2015 NHMRC Development Grant for 'Development of a New Specific Immunosuppressive Monoclonal Antibody to Advance Transplantation.' She actively contributes to the immunology community through her membership in the Australasian Society of Immunology, Human Cell Differentiation Molecules Council (which oversees the HLDA Workshops for CD molecule nomenclature), and Sydney Cancer Partners.

• Systems Biology
• Immunomics
• Immune Aging
• +۵ مورد دیگر

Lorenzo Bonaguro is a Group Leader in Molecular and Translational Immunomics at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, with a dual appointment at the University Clinic Bonn (UKB). His research integrates systems biology approaches with advanced computational methods to understand immune system aging and its relationship to environmental factors. His educational background includes: Ph.D. in Molecular Biomedicine from the University of Bonn (2020), with dissertation "Creld1 controls T cell homeostasis in mouse and human" (summa cum laude) M.S. in Pharmaceutical Biotechnologies from the University of Padova B.S. in Health Biotechnologies from the University of Padova Bonaguro's research focuses on understanding how environmental factors such as diet and pollution influence immune system aging and vaccine response. His team employs single-cell RNA sequencing, tonsil organoids, and artificial intelligence to unravel the molecular determinants of immune fitness. The ultimate goal of his work is to develop precision medicine strategies that enable tailored treatments for individual patients, leading to more effective and personalized healthcare approaches. His scientific contributions have been recognized with several prestigious awards: Renate und Karlheinz Schmidt-Stiftung Award (Early Academic Award, 2023) Best publication award from Bonner Forum Biomedicine (2020) Best poster award from Bonner Forum Biomedicine (2018) Bonaguro has secured significant third-party funding for his research, including an ERC Starting Grant (POLIS) for 2025-2030 to investigate the chronic impact of PFAS on the adaptive immune system, ImmunoSensation2 funding (2023-2025), and DFG funding for the ImmuDiet project (2023-2026). He has developed computational tools including cyCONDOR for high dimensionality flow cytometry analysis, Clinical Match for avoiding sample preparation batch effects in omics data, and huva for human variation analysis. He leads the Bonaguro Lab which combines biological expertise with advanced technological approaches to address critical scientific questions in immunology. His scholarly impact is reflected in a citation count of 4013, an h-index of 15, and an i10-index of 17.

Ryan Pinkمشاهده پروفایل

مدرس ارشد

• Extracellular Vesicle Biology
• Cancer Cell Communication
• Genomic Technologies
• +۵ مورد دیگر

Ryan Pink is a Senior Lecturer in Molecular Biology and Genomics at the School of Biological and Medical Sciences , Oxford Brookes University. His career spans teaching medical genomics, leading extracellular vesicle research in cancer biology, and founding spinout company MetaGuideX . He serves as board member of the UK Society for Extracellular Vesicles and develops digital diagnostic technologies. PhD, MSc, BSc (Hons) in Molecular Biosciences Academic Health Science Centre representative for Oxford Brookes Co-founder of Brookes Data Club for bioinformatics training Research focuses on extracellular vesicle communication in disease with particular application to cancer diagnostics and therapies. His work on exosome profiling and glycan analysis has produced international publications and patents. Key projects include EV-based blood biopsies and glycosylation pattern analysis in breast cancer progression. His recent publications demonstrate growing specialization in EV standardization (MISEV2023 guidelines), metabolic disease models (AKR1D1 knockout studies), and bioactive vesicle applications (plant-derived EV research). Collaborative work spans NHS, TheHill, and Oxford University Hospitals through the Academic Health Partners network. Scientific leadership includes: Chairing international EV conferences Editorial board contributions to Journal of Extracellular Vesicles MRC and Royal Society grant recipient Co-inventor of multiple cancer diagnostic patents As founder of the Oxford Brookes Science Bazaar festival, he has maintained annual public engagement programming since 2013, integrating artistic collaborations (dance/music/visual) that earned RSA Fellowship and BBC Science Engagement Award .

Chinten James Limمشاهده پروفایل

دانشیار

• Cancer progression and metastasis
• Solid cancer tumours
• Hematological tumours
• +۹ مورد دیگر

Chinten James Lim is an Associate Professor at the Faculty of Medicine , University of British Columbia, affiliated with the Department of Pediatrics and BC Children's Hospital Research Institute . His research spans cancer progression and metastasis , medical and biomedical engineering , and pediatric oncology . Major research areas : Tumour cell biology, mechanisms of drug resistance, and tumour microenvironment interactions. Methodologies : Patient-derived xenografts (PDX), proteomics, and integrin biology. Recent publications highlight his work in precision oncology , particularly using proteomics to identify treatment strategies for progressive malignancies. His team has developed personalized xenograft models to study disease evolution and therapy sensitivity in pediatric cancers. Dr. Lim’s lab investigates drug resistance mechanisms in hematological tumors (e.g., B-ALL) and solid cancers, focusing on integrin signaling pathways (e.g., RHAMM-TPX2-Aurora A interactions) and immunophenotype stability. He also explores innovative therapies for airway inflammation and fibroblast transplantation rejection. His work is supported by collaborations with BC Children's Hospital BioBank , Interdisciplinary Oncology Program , and Sunny Hill Health Centre . He supervises graduate students in Cell and Developmental Biology and Women+ and Children's Health Sciences programs.

Annie Millerمشاهده پروفایل

پژوهشگر ارشد

• Epigenetics
• Ophthalmology
• Molecular Biology
• +۳ مورد دیگر

Annie Miller is an Adjunct Research Fellow at the UWA Medical School, affiliated with the Centre for Ophthalmology and Visual Science and the Lions Eye Institute. Her work focuses on inherited retinal diseases, epigenetics, and neuroprotection in photoreceptor degeneration. Doctor of Philosophy (Ophthalmology and Visual Science), 2020-2024 Master of Clinical Pathology (Haematology, Microbiology), 2020 Bachelor of Science (Biomedical Sciences), 2017 Her research leverages mouse models and epigenetic analysis to explore therapeutic strategies for retinal degeneration. Recent work includes AAV capsid bioengineering for gene therapy and investigations into histone modifications. Research outputs highlight collaborations with institutions like the Harry Perkins Institute of Medical Research and Lions Eye Institute, with expertise in flow cytometry, explant cultures, and chromatin remodeling studies. Publications span therapeutic epigenetic targeting, neuroprotective treatments, and genetic mouse model validation. Annie actively contributes to translational research, bridging molecular biology and clinical ophthalmology. Current roles include Research Associate at Lions Eye Institute (2025-present) and former positions at Harry Perkins Institute (2018-2024).

Perumal Thiagarajanمشاهده پروفایل

استاد

• Cell Biology
• Hematology
• Molecular Biology
• +۳ مورد دیگر

Perumal Thiagarajan, M.D. is a Professor at Baylor College of Medicine , with dual appointments in the Department of Pathology & Immunology and Department of Medicine . He serves as Medical Director of the Blood Bank and Clinical Hematology Laboratory at the Michael E. DeBakey VA Medical Center and is a Core Faculty member at the Center for Translational Research on Inflammatory Diseases (CTRID) . His research focuses on erythroid cell biology, coagulation mechanisms, and translational applications in hematology and inflammation. MBBS, Tirunelveli Medical College, India Internship & Residency: Mt. Sinai-Bronx VA Hospital Hematology/Oncology Fellowship: Cardeza Foundation, Jefferson Medical College Research Highlights: Dr. Thiagarajan's work spans autophagy in erythroid maturation, lactadherin-phosphatidylserine interactions, and microvesicle clearance in traumatic brain injury. His studies bridge molecular hematology with clinical applications in coagulopathy and inflammatory diseases. Publications & Trends: His recent work explores microvesicle dynamics in TBI (2018), autophagy regulation in erythroid cells (2008), and phosphatidylserine detection methods (2006). Key themes include hematopoiesis , cell surface signaling , and translational therapies . Scientific Recognition: Established Investigator Award, American Heart Association (1984-1989) E. Merck Gold Medal for Best Outgoing Student (1974) Member, Association of American Physicians Member, American Society of Clinical Investigation Affiliations: Active in the Dan L Duncan Comprehensive Cancer Center and council member of the American Heart Association Thrombosis Council. Holds certifications from the American Board of Internal Medicine, Hematology, and Pathology.

Solange Duhamelمشاهده پروفایل

دانشیار

• Marine Microbiology
• Biogeochemistry
• Microbial Adaptation
• +۳ مورد دیگر

Solange Duhamel is an Associate Professor in the Department of Molecular & Cellular Biology at the University of Arizona, where she leads the Duhamel Lab for Marine Microbiology and Biogeochemistry. Her research focuses on aquatic microbial communities, including their roles in biogeochemical transformations, adaptations to extreme environments, and responses to climate stressors like temperature increases. She integrates field studies with laboratory experiments and advanced techniques such as NanoSIMS for single-cell analysis. Research Interests: Marine and freshwater microbial ecology Phosphorus and nitrogen cycling in oligotrophic systems Microbial adaptation to nutrient limitation and extreme environments Interactions between microbes and higher organisms (e.g., salamander-alga symbiosis) Application of flow cytometry and isotopic tracing in microbial studies Implications of microbial processes for planetary habitability Scientific Trends: Recent publications emphasize phosphorus dynamics in marine systems, microbial responses to climate stressors, and interdisciplinary approaches to understanding nutrient cycling. Her work bridges ecology, biogeochemistry, and astrobiology, particularly through studies of extremophiles in Icelandic hydrothermal systems as Mars analogues. Labs & Collaborations: Duhamel Lab for Marine Microbiology and Biogeochemistry Joint Faculty in Molecular & Cellular Biology Collaborations in satellite ocean color validation and BGC-Argo float data analysis

Barina Aqilمشاهده پروفایل

استادیار

• Hematopathology
• Hematologic Malignancies
• Leukemia
• +۳ مورد دیگر

Dr. Barina Aqil serves as Assistant Professor of Pathology specializing in Hematopathology at Northwestern University Feinberg School of Medicine. Board-certified in Anatomic/Clinical Pathology and Hematopathology, she maintains clinical affiliations with Northwestern Memorial Hospital and focuses on diagnostic excellence in hematologic malignancies. Education: MBBS: Jawaharlal Nehru Medical College, AMU, India (2005) Residency: Jawaharlal Nehru Medical College (2008) Residency: Baylor College of Medicine, Anatomic/Clinical Pathology (2015) Fellowship: Washington University School of Medicine, Hematopathology (2016) Fellowship: Washington University School of Medicine, Head and Neck Pathology (2017) Her research centers on hematopathology diagnostics, particularly applying flow cytometry and molecular techniques to leukemia/lymphoma classification. Recent work emphasizes real-world diagnostic validation and genomic prognostication in myeloid neoplasms, reflecting her commitment to translating laboratory findings into clinical practice. Publications from 2024-2025 demonstrate expertise in chronic myelomonocytic leukemia diagnostics, AML with core-binding factor abnormalities, TP53-mutated malignancies, and MYC-driven lymphoma – highlighting trends toward precision diagnostics using cytogenetic and molecular markers. Scientific Awards: ABPath swag award (2024) Outstanding Teacher Pin, Feinberg School of Medicine (2024) As an active educator, Dr. Aqil mentors medical trainees while maintaining membership in the American Society of Hematology. Her clinical work integrates with Northwestern Memorial Hospital's pathology services, emphasizing diagnostic accuracy and educational leadership within hematopathology.

Daniel Kaufmannمشاهده پروفایل

استاد

• Virology
• Immunology
• HIV Immunopathology
• +۴ مورد دیگر

Dr. Daniel E. Kaufmann is a Full Professor at the University of Montreal , operating through the CRCHUM (University of Montreal Hospital Research Center) and its Immunopathology Research Axis . He holds dual appointments in the Departments of Medicine and Microbiology, Infectious Diseases and Immunology , combining clinical expertise as an Infectious Disease Consultant at CHUM with cutting-edge research. His laboratory specializes in CD4 T cell immunobiology during HIV infection , investigating immune exhaustion mechanisms (PD-1, CTLA-4, IL-10 pathways) and developing innovative tools like RNA-FISH flow cytometry for single-cell viral reservoir tracking. Recent work extends to SARS-CoV-2 immunopathology , including breakthrough infection dynamics in immunocompromised individuals. Key research areas : T cell dysfunction in chronic viral infections Viral reservoir characterization Immunotherapeutic strategies for HIV/COVID-19 Host genetics of critical SARS-CoV-2 outcomes Scientific accolades : Fonds en Recherche Québec Santé (FRQS) Merit Researcher Grants from CIHR , NIH , CFI , and Bill & Melinda Gates Foundation Academic leadership : Serves on international review committees for grants and journals, while mentoring students at all levels in immunovirology techniques and analysis.

Heather Melicharمشاهده پروفایل

دانشیار

• Immunology
• T Cell Development
• Cellular and Molecular Mechanisms
• +۴ مورد دیگر

Dr. Heather Melichar is an Associate Professor in the Department of Medicine at the University of Montreal, where she leads a research group at the Maisonneuve-Rosemont Hospital Research Center. With a PhD from the University of Massachusetts Medical School and postdoctoral training at UC Berkeley, her work focuses on the cellular and molecular mechanisms regulating T cell development and function, particularly through thymic microenvironment interactions. Doctoral: University of Massachusetts Medical School (Dr. Joonsoo Kang lab) Postdoctoral: University of California, Berkeley (Dr. Ellen Robey lab) Her research employs advanced techniques like multiparameter flow cytometry, two-photon microscopy, and genetically modified mouse models to investigate: TCR selection thresholds during thymocyte development Age-related differences in thymic selection Role of tissue-restricted antigens in mTEC Tumor-immune cell interactions via novel protein-protein signaling Key article trends reveal sustained focus on developmental immunology, with recent expansions into neuroimmunology, metabolic disorders, and tumor immunology. Her 2023-2025 work includes translational studies on navitoclax therapy and epigenetic impacts of early-life infections. Scientific awards include FRSQ and CIHR fellowships. Current grants support investigations into vitamin D signaling in thymic aging and tumor-immune crosstalk. She supervises graduate students and postdoctoral fellows in laboratory projects, while co-supervising with interdisciplinary collaborators in genetics and oncology.

• Vertebrate Organ Development
• Genetic Regulatory Networks
• Stem Cell Regeneration
• +۳ مورد دیگر

Richard Maas is a Professor at Harvard Medical School affiliated with Brigham and Women's Hospital, leading the Maas Laboratory focused on vertebrate organ development and regeneration. His research spans two primary areas: (1) Systems-based Consortium for Organ Design and Engineering (SysCODE), a $24M NIH-funded initiative for stem cell-based organ regeneration, and (2) mechanistic studies of Pax6 , Hox , and related genes in eye, craniofacial, pancreatic, and kidney development. Key affiliations: Brigham and Women's Hospital, Harvard Medical School, NIH SysCODE Consortium Research domains: Developmental genetics, gene networks, interdisciplinary regenerative medicine His lab employs experimental embryology, molecular genetics, and computational approaches to unravel evolutionary conserved pathways in organogenesis, with applications to human birth defects. Current projects include regenerating tooth germ, pancreatic islets, and heart valves through multidisciplinary collaboration. Scientific contributions include: Establishing causal roles of genes like ROBO2 , NFIA , and SUMO1 in renal and craniofacial defects Developing iSyTE computational platform for eye gene discovery Characterizing molecular blueprints for tissue engineering through genomic/proteomic integration The lab actively trains students and postdocs through NIH-funded interdisciplinary programs, with a focus on bridging developmental biology and bioengineering.